Chapter 1: Introduction to Nephrocardiology Section 1: Heart Failure and pulmonary hypertension Chapter 2 : Introduction to cardiorenal syndrome Chapter 3 : Assessment of volume status Chapter 4 : Optimization of volume Chapter 5 : Approach to the other aspects of cardiorenal syndrome besides hemodynamics Chapter 6 : Combined Heart and Kidney Transplantation Chapter 7 : Cardiogenic Shock Chapter 8: Nephrocardiologic aspects of pulmonary hypertension Section 2: Ischemic Heart Disease Chapter 9: Epidemiology and pathophysiology of Ischemic heart disease in patients with Kidney Disease Chapter 10: Approach to Ischemic heart disease in the presence of Kidney Disease Chapter 11: Nephrology related conditions associated with Acute Coronary Syndrome Section 3: Cardiac Arrhythmias Chapter 12 : Atrial fibrillation Chapter 13 : Sudden cardiac arrest Section 4: Valvular Heart Diseases Chapter 14 : Valvular heart disease associated with chronic Kidney disease Chapter 15 : Nephrology related conditions associated with valvular heart diseases Section 5: Congenital Heart Diseases Chapter 16: Mutual impact of kidney function and various congenital heart diseases Chapter 17: Electrolyte and acid base abnormalities associated with congenital heart diseases Section 6: Systemic Hypertension Chapter 18 : Overview of definition, diagnosis, prognosis, and management of hypertension Chapter 19 : Hypertension and kidney diseases Chapter 20 : Hypertension and cardiovascular diseases Chapter 21: Management of refractory hypertension Section 7: Vascular Disorders Chapter 22 : Endothelial dysfunction, the heart and the kidneys Chapter 23 : Microangiopathy, the heart and the kidneys Chapter 24 : Atherosclerotic vascular diseases in patients with and without CKD Chapter 25: Vascular calcification in CKD and uremia Chapter 26 : Renovascular diseases Section 8: Common Risk Factors in Nephrology and Cardiovascular Medicine Chapter 27: Diabetes Mellitus Chapter 28: Dyslipidemia Chapter 29 : Hyperuricemia Chapter 30: Obesity and kidney Chapter 31: Obesity and cardiovascular system Chapter 32: Environmental pollutions Section 9: Systemic Diseases that Impact Kidney and Cardiovascular System 9.1 Autoimmune Disease Chapter 33: Systemic Lupus Erythematosus Chapter 34: Systemic Sclerosis Chapter 35: Rheumatoid Arthritis Chapter 36: Antiphospholipid Syndrome Chapter 37: Psoriasis 9.2 Metabolic Disorders Chapter 38 : Amyloidosis Chapter 39: Wilson disease 9.3 Ciliopathies Chapter 40: Autosomal Dominant Polycystic Kidney Disease Chapter 41: Autosomal Recessive Polycystic Kidney Disease 9.4 Other Ciliopathies Chapter 42: Medullary sponge kidney, Nephronophthisis, and medullary cystic Kidney disease 9.5 Other Hereditary Disorders Chapter 43: Fabry''s Disease Chapter 44: Alport Syndrome Chapter 45: Marfan Syndrome 9.6 Other Systemic Disorders that involve renal and cardiovascular systems Chapter 46: Sarcoidosis Chapter 47: Preeclampsia Section 10: Chronic Kidney Disease and Cardiovascular System Chapter 48 : Uremic toxins and intestinal microbiota, the kidney and the cardiovascular system Chapter 49 : Mineral metabolism, the kidney and the cardiovascular system Chapter 50 : Anemia, the kidney and the cardiovascular system Chapter 51 : Inflammation and Oxidative Stress, the kidney and the cardiovascular system Section 11: Cardiovascular interactions with nephrological interventions Chapter 52: Cardiovascular interactions of hemodialysis Chapter 53: Cardiovascular interactions of peritoneal dialysis Chapter 54: Cardiovascular interactions of kidney transplantation Chapter 55: Nephrology medications with cardiotoxicity and other cardiovascular impact Section 12: Nephrological interactions with Cardiovascular interventions Chapter 56: Advanced heart failure devices and cardiac resynchronization therapy Chapter 57: Cardiac transplantation Chapter 58: Intravascular contrast material Chapter 59: Other nephrotoxic drugs and medications with nephrological interactions Chapter 60: Selection and Dosing of Cardiovascular Medications in the presence of nephrology related conditions Section 13: Cardiovascular System and Electrolyte and Acid-Base Dysregulations Chapter 61: Abnormalities of potassium Chapter 62: Abnormalities of sodium Chapter 63: Abnormalities of magnesium Chapter 64: Acid-base dysregulations Section 14: Other Connections between Nephrology and Cardiovascular Medicine Chapter 65: Nephrolithiasis and coronary artery disease Chapter 66: Renal glomerular diseases and cardiovascular diseases Section 15: New Medications and State of the Art Methos and Technologies Chapter 67: New hypoglycemic agents Chapter 68: New mineralocorticoid receptor antagonists Chapter 69: Point of care ultrasound Section 18: Future Horizon Chapter 70: Areas of further studies in nephrocardiology Chapter 71: The future of Nephrocardiology.